Company intelligence / Profile preview
Clover Biopharmaceuticals
Chengdu, Sichuan, Chinacloverbiopharma.com ↗
- Ownership
- Public · 2197
- Development stage
- Commercial
01
Overview
Clover Biopharmaceuticals developed a protein-based COVID‑19 vaccine using its proprietary Trimer‑Tag technology and supplied doses under global partnerships. The company’s COVID program has been discontinued after regulatory and commercial challenges. Its lead pipeline asset now is an RSV vaccine candidate, SCB–1019, which has shown positive Phase I data compared to GSK’s Arexvy and recently received IND clearance from the US FDA to begin further clinical studies.[1][4][5]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Protein-based vaccines (notably Trimer-tagged subunit vaccines)[1][4]Recombinant biologics/therapeutic proteins[3]
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
Request access →03
Partnerships
Gavi, the Vaccine Alliance (terminated advance purchase agreement for COVID shot)[5]Other global health organizations mentioned but not named specifically
Beyond the preview
Go deeper on Clover Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clover Biopharmaceuticals.